BRight DCB

DEVICE2 trials

Sponsors

Biotronik CRC Inc.

Conditions

Peripheral Artery Disease

Unknown Phase

BRight DCB First-in-Human Study

CompletedNCT04525794

Biotronik CRC Inc.Peripheral Artery Disease

Start: 2021-02-04End: 2024-02-02Updated: 2024-05-22

BRight Pharmacokinetic Study

CompletedNCT06065345

Biotronik CRC Inc.Peripheral Artery Disease

Start: 2024-05-01End: 2025-07-22Updated: 2025-09-05